Neurogenesis, neural stem cells and nitric oxide in neuroinflammation
Author: Danilov, Alexandre I
Date: 2005-10-14
Location: Centrum för Molekylär Medicin (CMM) L8:00, Karolinska Universitetssukhuset, Solna
Time: 9.00
Department: Institutionen för molekylär medicin / Department of Molecular Medicine
Abstract
We investigated whether nitric oxide (NO) is produced in MS patients, determining the concentrations of its oxidation products (NOx) in CSF. The total levels of NOx in CSF were significantly increased in all MS groups as compared to healthy controls and tension headache patients. Since CSF nitrite levels correlated with clinical disease activity the determination of nitrite levels may be used as a surrogate marker for disease activity.
Systemically and intrathecally produced nitric oxide might play different roles in EAE pathogenesis. We therefore administered the NOS inhibitor L-NAME intrathecally or systemically via osmotic minipumps to DA rats with MOG-induced experimental autoimmune encephalomyelitis (EAE). NOS inhibition decreased EAE severity, the extent of CNS inflammation and demyelination. Intrathecal administration was more effective than systemic administration. The observed effect was accompanied by enhanced anti-MOG IgG1 production.
Next we examined if NOS and reactive oxygen species (ROS) inhibition would be beneficial in a traumatic brain injury model (TBI). We administered NOS inhibitor (LNAME) alone and in combination with nitrone radical scavenger (S-PBN) after TBI. NOS inhibition and ROS scavenging significantly reduced neuronal degeneration, possibly via limiting peroxynitrite formation and thus promoting neuronal survival. The combination of LNAME and S-PBN was neuroprotective, but no additive effect was achieved.
We also studied the possible activation and differentiation of central nervous system (CNS) stem cells in EAE lesioned spinal cord. Labelled stem cells from the ependymal layer in the spinal cord respond to the MS-like condition by proliferation and migration into demyelinated areas. Some of the theses cells expressed oligodendrocyte and astrocyte markers. Macrophage attacks on the stem cell population were observed.
We have also addressed the question whether neurogenesis can occur in neuroinflammatory lesions. We found that the progeny of labelled ependymal cells proliferate and migrate to the neuroinflammatory lesions, differentiating into cells expressing neuronal markers. These cells were immunoreactive for markers of cells undergoing cell-proliferation. Freshly isolated DiI labelled cells from spinal cord lesions were able to fire overshooting action potentials comparable to those of immature neurons. We provide the first evidence for neurogenesis in neuroinflammatory lesions in the adult spinal cord.
Accordingly, we investigated the effects of NO exposure on the fate acquisition of neuronal stem cells. Neurogenesis was suppressed and gliogenesis promoted. The suggested mechanisms were related to downregulation of neurogenin-2 and activation of the JAK/STAT- 1 signal transduction pathway.
Systemically and intrathecally produced nitric oxide might play different roles in EAE pathogenesis. We therefore administered the NOS inhibitor L-NAME intrathecally or systemically via osmotic minipumps to DA rats with MOG-induced experimental autoimmune encephalomyelitis (EAE). NOS inhibition decreased EAE severity, the extent of CNS inflammation and demyelination. Intrathecal administration was more effective than systemic administration. The observed effect was accompanied by enhanced anti-MOG IgG1 production.
Next we examined if NOS and reactive oxygen species (ROS) inhibition would be beneficial in a traumatic brain injury model (TBI). We administered NOS inhibitor (LNAME) alone and in combination with nitrone radical scavenger (S-PBN) after TBI. NOS inhibition and ROS scavenging significantly reduced neuronal degeneration, possibly via limiting peroxynitrite formation and thus promoting neuronal survival. The combination of LNAME and S-PBN was neuroprotective, but no additive effect was achieved.
We also studied the possible activation and differentiation of central nervous system (CNS) stem cells in EAE lesioned spinal cord. Labelled stem cells from the ependymal layer in the spinal cord respond to the MS-like condition by proliferation and migration into demyelinated areas. Some of the theses cells expressed oligodendrocyte and astrocyte markers. Macrophage attacks on the stem cell population were observed.
We have also addressed the question whether neurogenesis can occur in neuroinflammatory lesions. We found that the progeny of labelled ependymal cells proliferate and migrate to the neuroinflammatory lesions, differentiating into cells expressing neuronal markers. These cells were immunoreactive for markers of cells undergoing cell-proliferation. Freshly isolated DiI labelled cells from spinal cord lesions were able to fire overshooting action potentials comparable to those of immature neurons. We provide the first evidence for neurogenesis in neuroinflammatory lesions in the adult spinal cord.
Accordingly, we investigated the effects of NO exposure on the fate acquisition of neuronal stem cells. Neurogenesis was suppressed and gliogenesis promoted. The suggested mechanisms were related to downregulation of neurogenin-2 and activation of the JAK/STAT- 1 signal transduction pathway.
List of papers:
I. Danilov AI, Andersson M, Bavand N, Wiklund NP, Olsson T, Brundin L (2003). Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol. 136(1-2): 112-8.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Danilov AI, Jagodic M, Wiklund NP, Olsson T, Brundin L (2005). Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE. Nitric Oxide. Aug 12.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Gahm C, Danilov AI, Holmin S, Wiklund NP, Brundin L, Mathiesen T (2005). Reduced neuronal injury after treatment withNG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery. [Accepted]
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Brundin L, Brismar H, Danilov AI, Olsson T, Johansson CB (2003). Neural stem cells: a potential source for remyelination in neuroinflammatory disease. Brain Pathol. 13(3): 322-8.
Pubmed
View record in Web of Science®
V. Danilov AI, Covacu R, Moe MC, Langmoen IA, Johansson CB, Olsson T, Brundin L (2005). Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis. [Submitted]
VI. Covacu R, Danilov AI, Sonnich Rasmussen B, Hallen K, Moe MC, Lobell A, Johansson CB, Olsson T, Brundin L (2005). Nitric oxide exposure diverts neural stem cell fate. [Submitted]
I. Danilov AI, Andersson M, Bavand N, Wiklund NP, Olsson T, Brundin L (2003). Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol. 136(1-2): 112-8.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Danilov AI, Jagodic M, Wiklund NP, Olsson T, Brundin L (2005). Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE. Nitric Oxide. Aug 12.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Gahm C, Danilov AI, Holmin S, Wiklund NP, Brundin L, Mathiesen T (2005). Reduced neuronal injury after treatment withNG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery. [Accepted]
Fulltext (DOI)
Pubmed
View record in Web of Science®
IV. Brundin L, Brismar H, Danilov AI, Olsson T, Johansson CB (2003). Neural stem cells: a potential source for remyelination in neuroinflammatory disease. Brain Pathol. 13(3): 322-8.
Pubmed
View record in Web of Science®
V. Danilov AI, Covacu R, Moe MC, Langmoen IA, Johansson CB, Olsson T, Brundin L (2005). Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis. [Submitted]
VI. Covacu R, Danilov AI, Sonnich Rasmussen B, Hallen K, Moe MC, Lobell A, Johansson CB, Olsson T, Brundin L (2005). Nitric oxide exposure diverts neural stem cell fate. [Submitted]
Issue date: 2005-09-23
Publication year: 2005
ISBN: 91-7140-484-8
Statistics
Total Visits
Views | |
---|---|
Neurogenesis, ...(legacy) | 183 |
Neurogenesis, ... | 172 |
Total Visits Per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Neurogenesis, ... | 3 | 0 | 1 | 0 | 0 | 1 | 2 |
Top country views
Views | |
---|---|
United States | 112 |
Germany | 71 |
Sweden | 39 |
China | 27 |
Ireland | 7 |
South Korea | 7 |
Finland | 6 |
Canada | 4 |
Hong Kong | 4 |
Iran | 3 |
Top cities views
Views | |
---|---|
Ashburn | 47 |
Kiez | 21 |
Lansing | 16 |
Shenzhen | 8 |
Dublin | 7 |
Seoul | 6 |
Beijing | 5 |
Tianjin | 5 |
Malmo | 4 |
Easton | 3 |